Food and Drug Administration Approval of First Biosimilar Product

First Page		Document Content
Date: 2015-05-17 22:49:38 Federal assistance in the United States Healthcare reform in the United States Presidency of Lyndon B. Johnson Vaccines Medicare Biosimilar Biologic Influenza FluMist Medicine Health Pharmacology		Food and Drug Administration Approval of First Biosimilar Product Add to Reading List Source URL: www.cms.gov Download Document from Source Website File Size: 78,65 KB Share Document on Facebook

	USHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FLUMIST® QUADRIVALENT safely and effectively. See full prescribing information for FLUMIST® QUADRIVALENT. DocID: 1uLgf - View Document
	NEW INFORMATION REGARDING FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal) June 23, 2016 Dear Healthcare Provider, As you plan for the upcominginfluenza season, we are writing to inform you of the r DocID: 1smfp - View Document
	An#actor)network#approach#to#HCW# inﬂuenza#immunisa8on#in#Wales# # # Rachel#Hale# DocID: 1gFhA - View Document
	FACTS SHEET 13 August 2013 New Hendra Virus Vaccination Program Racing Queensland (RQ) will offer a subsidised Hendra Virus vaccination program to all registered DocID: 1gnNb - View Document
	To Flu or Not to Flu? It’s cold and flu season again, but is a vaccine really the best way to protect you and your family? by Sarah McCoy Juggling a full-time job and a 2 year old, Christy Fore counts on the ﬂu vacci DocID: 1genR - View Document